The 5-amino-1MQ peptide has gained significant attention in metabolic research for its unique ability to increase intracellular NAD+ (nicotinamide adenine dinucleotide) levels by inhibiting the NNMT enzyme
This is an individual choice, one that ought to rest on your own bloodwork rather than population averages
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Ik maak beelden die je verhaal vertellen.
Follow-Up: Regular follow-up appointments to monitor your progress and adjust your treatment as necessary.
For example, a single jab might be 40, but a "loading course" of six doses could be offered for 180, bringing the price per shot down to 30